A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-13
DOI
10.1038/s41598-021-89478-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- Analysis of Drug Effects on iPSC Cardiomyocytes with Machine Learning
- (2020) Martti Juhola et al. ANNALS OF BIOMEDICAL ENGINEERING
- Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques
- (2020) Cassady E. Rupert et al. PLoS One
- An evaluation framework for new approach methodologies (NAMs) for human health safety assessment
- (2020) Stanley T. Parish et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity
- (2020) Dylan J. Richards et al. Nature Biomedical Engineering
- Human Cardiac Fibroblast Number and Activation State Modulate Electromechanical Function of hiPSC-Cardiomyocytes in Engineered Myocardium
- (2020) Cassady E. Rupert et al. Stem Cells International
- A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
- (2019) Yimu Zhao et al. CELL
- Electrophysiological characterization of drug response in hSC-derived cardiomyocytes using voltage-sensitive optical platforms
- (2019) Emily R. Pfeiffer-Kaushik et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association
- (2019) Gary Gintant et al. CIRCULATION RESEARCH
- Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery
- (2019) Nicole T Feric et al. TOXICOLOGICAL SCIENCES
- Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems
- (2018) Tarek Magdy et al. Annual Review of Pharmacology and Toxicology
- Quantitatively characterizing drug-induced arrhythmic contractile motions of human stem cell-derived cardiomyocytes
- (2018) Plansky Hoang et al. BIOTECHNOLOGY AND BIOENGINEERING
- Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications
- (2018) Péter Ferdinandy et al. EUROPEAN HEART JOURNAL
- Differences in ion channel phenotype and function between humans and animal models
- (2018) Christine Beeton Frontiers in Bioscience-Landmark
- Predicting drug-induced arrhythmias by multiscale modeling
- (2018) Francisco Sahli Costabal et al. International Journal for Numerical Methods in Biomedical Engineering
- Brugada-Type Pattern on Electrocardiogram Associated with High-Dose Loperamide Abuse
- (2018) Christie Sun et al. JOURNAL OF EMERGENCY MEDICINE
- Directed fusion of cardiac spheroids into larger heterocellular microtissues enables investigation of cardiac action potential propagation via cardiac fibroblasts
- (2018) Tae Yun Kim et al. PLoS One
- Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies
- (2018) Judy Strickland et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells
- (2018) Maki Takeda et al. TISSUE ENGINEERING PART C-METHODS
- Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study
- (2018) Daniel Millard et al. TOXICOLOGICAL SCIENCES
- Bringing in vitro analysis closer to in vivo : Studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling
- (2018) Marcha Verheijen et al. TOXICOLOGY LETTERS
- Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes
- (2018) Diogo Ramalho et al. Revista Portuguesa de Cardiologia
- Characterization and Validation of a Human 3D Cardiac Microtissue for the Assessment of Changes in Cardiac Pathology
- (2018) Caroline R. Archer et al. Scientific Reports
- International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
- (2018) Ksenia Blinova et al. Cell Reports
- Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting
- (2018) David G. Strauss et al. Therapeutic Innovation & Regulatory Science
- Electrophysiological evaluation of pentamidine and 17-AAG in human stem cell-derived cardiomyocytes for safety assessment
- (2018) Yumiko Asahi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Resolving the Reversed Rate Effect of Calcium Channel Blockers on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and the Impact on In Vitro Cardiac Safety Evaluation
- (2018) Haoyu Zeng et al. TOXICOLOGICAL SCIENCES
- Comprehensive human stem cell differentiation in a 2D and 3D mode to cardiomyocytes for long-term cultivation and multiparametric monitoring on a multimodal microelectrode array setup
- (2018) Stephan Fleischer et al. BIOSENSORS & BIOELECTRONICS
- In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish
- (2017) Celinda M. Kofron et al. JOURNAL OF PHYSIOLOGY-LONDON
- In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model
- (2017) Oksana Sirenko et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Comprehensive in vitro cardiac safety assessment using human stem cell technology: Overview of CSAHi HEART initiative
- (2017) Kiyoshi Takasuna et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes
- (2017) Wesley L. McKeithan et al. Frontiers in Physiology
- Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
- (2017) Sara Dutta et al. Frontiers in Physiology
- Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3′,5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
- (2017) Bin Lin et al. Frontiers in Endocrinology
- Cardiac spheroids as promising in vitro models to study the human heart microenvironment
- (2017) Liudmila Polonchuk et al. Scientific Reports
- Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening
- (2016) Yosuke K. Kurokawa et al. ADVANCED DRUG DELIVERY REVIEWS
- Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems
- (2016) Jason Pellman et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
- (2016) Ian Y. Chen et al. Nature Reviews Cardiology
- Evolution of strategies to improve preclinical cardiac safety testing
- (2016) Gary Gintant et al. NATURE REVIEWS DRUG DISCOVERY
- Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients
- (2016) A. Heranval et al. REVUE NEUROLOGIQUE
- Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues
- (2016) Stephanie M. Ravenscroft et al. TOXICOLOGICAL SCIENCES
- From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery
- (2016) Amy Pointon et al. TOXICOLOGICAL SCIENCES
- An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
- (2016) William J. Crumb et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias
- (2016) Aimee Lee et al. Critical Care Nursing Clinics of North America
- Antiarrhythmic properties of ranolazine: A review of the current evidence
- (2015) Tanush Gupta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging
- (2015) Gunnar Bergström et al. LAB ON A CHIP
- Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes
- (2015) Philippe Beauchamp et al. TISSUE ENGINEERING PART C-METHODS
- Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform
- (2015) Yusheng Qu et al. TOXICOLOGICAL SCIENCES
- High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays
- (2015) Kristin H. Gilchrist et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
- (2015) J. Vicente et al. Journal of the American Heart Association
- Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp
- (2015) Yuji Haraguchi et al. BMC Pharmacology & Toxicology
- Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
- (2014) L Johannesen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D
- (2014) Toni-Marie Achilli et al. MOLECULAR PHARMACEUTICS
- Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing
- (2014) Daniel Sinnecker et al. PHARMACOLOGY & THERAPEUTICS
- Impact of Bisphenol A on the Cardiovascular System — Epidemiological and Experimental Evidence and Molecular Mechanisms
- (2014) Xiaoqian Gao et al. International Journal of Environmental Research and Public Health
- Microscale Generation of Cardiospheres Promotes Robust Enrichment of Cardiomyocytes Derived from Human Pluripotent Stem Cells
- (2014) Doan C. Nguyen et al. Stem Cell Reports
- Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
- (2013) Philip T. Sager et al. AMERICAN HEART JOURNAL
- In silico assessment of drug safety in human heart applied to late sodium current blockers
- (2013) Beatriz Trenor et al. Channels
- Screening Drug-Induced Arrhythmia Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays
- (2013) E. G. Navarrete et al. CIRCULATION
- A Novel 3D Label-Free Monitoring System of hES-Derived Cardiomyocyte Clusters: A Step Forward to In Vitro Cardiotoxicity Testing
- (2013) Heinz-Georg Jahnke et al. PLoS One
- Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells
- (2012) B. R. Desroches et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Standardization of pluripotent stem cell cultures for toxicity testing
- (2012) Francesca Pistollato et al. Expert Opinion on Drug Metabolism & Toxicology
- Cozzarelli Prize Winner: Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling
- (2012) X. Lian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
- (2011) Junyi Ma et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability
- (2011) Paul W. Burridge et al. PLoS One
- Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle?
- (2010) M. Grunnet Acta Physiologica
- So Little Source, So Much Sink: Requirements for Afterdepolarizations to Propagate in Tissue
- (2010) Yuanfang Xie et al. BIOPHYSICAL JOURNAL
- Drug-induced arrhythmias
- (2010) Brian J. Barnes et al. CRITICAL CARE MEDICINE
- Early afterdepolarizations and cardiac arrhythmias
- (2010) James N. Weiss et al. HEART RHYTHM
- Impact of ionic current variability on human ventricular cellular electrophysiology
- (2009) Lucía Romero et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Why animal studies are often poor predictors of human reactions to exposure
- (2009) Michael B Bracken JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Advances in mechanisms of atrial fibrillation: structural remodeling, high-frequency fractionated electrograms, and reentrant AF drivers
- (2008) Kevin J. Makati et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart
- (2008) N.C. Guérard et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Pharmacogenetics of drug-induced arrhythmias
- (2008) Geoffrey W Abbott et al. Expert Review of Clinical Pharmacology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started